Skip to main content

Advertisement

SpringerLink
Log in

TB or Not TB: Crohn’s Disease, Peritoneal Tuberculosis, or Both?

  • Stanford Multidisciplinary Seminars
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Du J, Ma YY, Xiang H, Li YM. Confluent granulomas and ulcers lined by epithelioid histiocytes: new ideal method for differentiation of ITB and CD? A meta analysis. PLoS ONE. 2014;9:e103303.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Ma JY, Tong JL, Ran ZH. Intestinal tuberculosis and Crohn’s disease: challenging differential diagnosis. J Dig Dis. 2016;17:155–161.

    Article  CAS  PubMed  Google Scholar 

  3. Limsrivilai J, Shreiner AB, Pongpaibul A, et al. Meta-analytic Bayesian model for differentiating intestinal tuberculosis from Crohn’s disease. Am J Gastroenterol. 2017;112:415–427.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Ince AT, Güneş P, Senateş E, et al. Can an immunohistochemistry method differentiate intestinal tuberculosis from Crohn’s disease in biopsy specimens? Dig Dis Sci. 2011;56:1165–1170. https://doi.org/10.1007/s10620-010-1399-7.

    Article  PubMed  Google Scholar 

  5. Banerjee R, Balaji M, Sasikala M, et al. Granulomas of intestinal tuberculosis and Crohn’s disease can be differentiated by CD73 cell surface marker expression: a pilot study. Dig Dis Sci. 2013;58:2301–2307. https://doi.org/10.1007/s10620-013-2667-0.

    Article  CAS  PubMed  Google Scholar 

  6. Jin XJ, Kim JM, Kim HK, et al. Histopathology and TB-PCR kit analysis in differentiating the diagnosis of intestinal tuberculosis and Crohn’s disease. World J Gastroenterol. 2010;16:2496–2503.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Gardam MA, Keystone EC, Menzies R, et al. Anti-tumor necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis. 2003;3:148–155.

    Article  CAS  PubMed  Google Scholar 

  8. Tissot C, Couraud S, Meng L, et al. Life-threatening disseminated tuberculosis as a complication of treatment by infliximab for Crohn’s disease: report of two cases, including cerebral tuberculomas and miliary tuberculosis. J Crohn’s Colitis. 2012;6:946–949.

    Article  Google Scholar 

  9. Milenković B, Dudvarski-Ilić A, Janković G, et al. Anti-TNF treatment and miliary tuberculosis in Crohn’s disease. Srp Arh Celok Lek. 2011;139:514–517.

    Article  PubMed  Google Scholar 

  10. Stewart RJ, Tsang CA, Pratt RH, Price SF, Langer AJ. Tuberculosis—United States, 2017. MMWR Morb Mortal Wkly Rep. 2018;67:317–323. https://doi.org/10.15585/mmwr.mm6711a2.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Wallis RS, Broder MS, Wong JY, et al. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis. 2004;38:1261–1265.

    Article  CAS  PubMed  Google Scholar 

  12. Dobler C. Biologic agents and tuberculosis. In: Schlossberg D, ed. Tuberculosis and Nontuberculous Mycobacterial Infections. 7th ed. Washington, DC: ASM Press; 2017:623–635. https://doi.org/10.1128/microbiolspec.tnmi7-0026-2016.

    Chapter  Google Scholar 

  13. Tubach F, Salmon D, Ravaud P, et al. Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: the three-year prospective French Research Axed on Tolerance of Biotherapies registry. Arthritis Rheum. 2009;60:1884–1894.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Kim Y, Kim YG, Shim TS, et al. Safety of resuming tumour necrosis factor inhibitors in patients who developed tuberculosis as a complication of previous TNF inhibitors. Rheumatology (Oxford). 2014;53:1477–1481.

    Article  CAS  Google Scholar 

  15. Lamb YN, Duggan ST. Ustekinumab: a review in moderate to severe Crohn’s disease. Drugs. 2017;77:1105–1114.

    Article  CAS  PubMed  Google Scholar 

  16. Jauregui-Amezaga A, Somers M, De Schepper H, Macken E. Next generation of biologics for the treatment of Crohn’s disease: an evidence-based review on ustekinumab. Clin Exp Gastroenterol. 2017;15:293–301.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Colorectal Surgery, Division of General Surgery, Stanford University School of Medicine, 300 Pasteur Drive. H3691, Stanford, CA, 94305, USA

    Miquell Miller, Andrew Shelton & Cindy Kin

  2. Department of Radiology, Stanford University School of Medicine, 300 Pasteur Drive., Stanford, CA, 94305, USA

    Kim-Nhien Vu

  3. Department of Pathology, Stanford University School of Medicine, 300 Pasteur Drive. H2210, Stanford, CA, 94305, USA

    Allison Zemek

Authors
  1. Miquell Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kim-Nhien Vu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Allison Zemek
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Andrew Shelton
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Cindy Kin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Miquell Miller.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Miller, M., Vu, KN., Zemek, A. et al. TB or Not TB: Crohn’s Disease, Peritoneal Tuberculosis, or Both?. Dig Dis Sci 64, 1432–1435 (2019). https://doi.org/10.1007/s10620-018-5334-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-018-5334-7

Search

Navigation